[News about HIV. Combination therapy with new drugs gives hope]

Natural occurrence of drug resistance mutations to the HIV-1 capsid inhibitor lenacapavir.

HIV medicine·2025

Low-level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression.

HIV medicine·2023

Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors.

HIV medicine·2020

Microfluidic centrifugation assisted precipitation based DNA quantification.

Lab on a chip·2019

A high rate of HIV-1 acquisition post immigration among migrants in Sweden determined by a CD4 T-cell decline trajectory model.

HIV medicine·2017

Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study.

BJOG : an international journal of obstetrics and gynaecology·2017

[Upper tract urothelial carcinoma - regional differences observed in several quality indicators].

Lakartidningen·2026

[Rare manifestations of giant cell arteritis].

Lakartidningen·2026

[Neoehrlichiosis in rituximab-treated patients with MS in Sweden].

Lakartidningen·2026

[The Swedish Neonatal Quality Register (SNQ) - a complete register for a complex chain of events].

Lakartidningen·2026

[Postoperative atrial fibrillation after open heart surgery].

Lakartidningen·2026

[Interaction between psychotic patients and AI-driven chatbots].

Lakartidningen·2026

Advances in MOF-Based Transdermal Drug Delivery Systems: Mechanisms, Applications, and Future Prospects.

Topics in current chemistry (Cham)·2026

Development and evaluation of 68Ga-DOTA-EP-1: A novel PET tracer targeting EpCAM for malignant tumor diagnosis.

Bioorganic chemistry·2026

An evaluation of denecimig for bleeding prophylaxis in hemophilia A.

Expert opinion on biological therapy·2026

Thyroid Artery Embolization: A Review and Considerations for the Interventional Radiologist.

Seminars in interventional radiology·2026

Expert assessment of the attributes of high-cost medications: a case study of CAR T-cell therapy in the gulf cooperation council.

Frontiers in pharmacology·2026

Longitudinal Outcomes of Dolutegravir-Based Antiretroviral Therapy in a Large Nigerian Programmatic HIV-1 Cohort, 2017-2019.

Open forum infectious diseases·2026

Related Experiment Videos

[News about HIV. Combination therapy with new drugs gives hope]

Related Concept Videos

Natural occurrence of drug resistance mutations to the HIV-1 capsid inhibitor lenacapavir.

Low-level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression.

Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors.

Microfluidic centrifugation assisted precipitation based DNA quantification.

A high rate of HIV-1 acquisition post immigration among migrants in Sweden determined by a CD4 T-cell decline trajectory model.

Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study.

[Upper tract urothelial carcinoma - regional differences observed in several quality indicators].

[Rare manifestations of giant cell arteritis].

[Neoehrlichiosis in rituximab-treated patients with MS in Sweden].

[The Swedish Neonatal Quality Register (SNQ) - a complete register for a complex chain of events].

[Postoperative atrial fibrillation after open heart surgery].

[Interaction between psychotic patients and AI-driven chatbots].

Advances in MOF-Based Transdermal Drug Delivery Systems: Mechanisms, Applications, and Future Prospects.

Development and evaluation of 68Ga-DOTA-EP-1: A novel PET tracer targeting EpCAM for malignant tumor diagnosis.

An evaluation of denecimig for bleeding prophylaxis in hemophilia A.

Thyroid Artery Embolization: A Review and Considerations for the Interventional Radiologist.

Expert assessment of the attributes of high-cost medications: a case study of CAR T-cell therapy in the gulf cooperation council.

Longitudinal Outcomes of Dolutegravir-Based Antiretroviral Therapy in a Large Nigerian Programmatic HIV-1 Cohort, 2017-2019.

Related Experiment Videos

[News about HIV. Combination therapy with new drugs gives hope]

Related Concept Videos

Related Articles